Pharmalink is a publicly held but unlisted company.
Pharmalink's administrative and financial management is operated out of Hong Kong, Germany and The Philippines.
The company contracts to Pharmalink Marketing Services Pty Ltd its marketing and production oversight functions in Australia.
Pharmalink supplies two different marine-based lipid fractions from the New Zealand green-shell mussel for use in formulations for the treatment of inflammatory conditions. Pharmalink products are sold throughout the Americas, Europe and Asia. In addition, Pharmalink has its own retail brand, Lyprinol®, which is sold in 23 countries. The company owns or is the exclusive beneficiary of the world-wide patents, trademarks and distribution rights for Lyprinol®.